Sanomedics to Demonstrate ThermoPet™ at Global Pet Expo, Booth 4089

MIAMI--(EON: Enhanced Online News)--Sanomedics International Holdings, Inc. (Pink Sheets:SIMH) will be publicly demonstrating ThermoPet™, the company’s unique and patent-pending non-contact thermometer for pets, at the Global Pet Expo - the pet industry’s largest annual tradeshow in the United States.

“Speed, accuracy, and extreme ease-of-use, allows practitioners to instantly assess an animal’s temperature. ThermoPet provides new operational efficiencies and safety to caregivers, while improving the overall quality of pet care.”

ThermoPet™ represents Sanomedics’ flagship product in the rapidly expanding $53 billion total estimated pet market, where over $10.2 billion is focused on supplies and pet health-related products.

“As much as we love our pets, it is a constant struggle to understand their health,” stated Keith Houlihan, President of Sanomedics International Holdings, Inc. “Fever is a primary indicator of major health issues in pets, and our ThermoPet system is the world’s first totally non-contact pet thermometer. As simple as pointing and pressing a button, ThermoPet does not use probes and does not require insertion anywhere inside a pet’s body. Fast and accurate, pet owners now know their animal’s temperature within a second. We at Sanomedics believe this pet medical device will have significant impact in keeping pets well. No longer will owners be forced to base pet-health decisions only on a warm nose or lethargic behavior. An accurate, non-invasive temperature reading can greatly assist pet owners when deciding if additional medical attention is warranted.”

According to industry estimates, approximately 63 percent of United States households own one or more pets. This equates to over 71 million households in need of a medical device like ThermoPet™, which would help pet owners determine fever and overall wellness of their pets. In particular, with over 44 million dog owners and in excess of 88 million cat owners, pets are considered to be true family members, a valued friend and protector. Pet owners increasingly spare no expense in the care and safety of their dog or cat.

“ThermoPet can also have significant impact within Veterinary practices,” added Abhishek Shrivastava, Chief Technology Officer and Executive Vice President of Sanomedics. “Speed, accuracy, and extreme ease-of-use, allows practitioners to instantly assess an animal’s temperature. ThermoPet provides new operational efficiencies and safety to caregivers, while improving the overall quality of pet care.”

ThermoPet™ will be on public display throughout the Global Pet Expo at Sanomedics booth 4089, with the show running from March 25-27 at the Orange County Convention Center in Orlando, Florida. For private or off-site demonstrations and distributor inquiries, please call (305) 433-7809 to schedule a dedicated appointment.

About Sanomedics

Sanomedics International Holdings, Inc. (SIMH) designs, develops and markets innovative medical health and wellness diagnostic products targeting three key markets -- professional medical service providers, consumer home healthcare, and the rapidly expanding health sector for pets. Capitalizing on the trend of personal responsibility for health and wellness for all family members, as well as an increasing focus nationally on preventative health as a means to control healthcare cost escalation, the goal of Sanomedics is to be the diagnostic bridge between the medical world and home.

Forward Looking Statements

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The company’s periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.